APO RESEARCH · REPORT
Phototherapy Treatment
Phototherapy is a type of medical treatment that involves exposure to fluorescent light bulbs or other sources of light like halogen lights, sunlight, and light emitting diodes (LEDs) to treat certain medical conditions.
Product & engineering
Understand the product.
Phototherapy is a type of medical treatment that involves exposure to fluorescent light bulbs or other sources of light like halogen lights, sunlight, and light emitting diodes (LEDs) to treat certain medical conditions.
This report is about Phototherapy device.
Selected research
Market Analysis & Forecast
Global Phototherapy Treatment Market Analysis and Forecast 2026-2032
Market perspective
Phototherapy is a type of medical treatment that involves exposure to fluorescent light bulbs or other sources of light like halogen lights, sunlight, and light emitting diodes (LEDs) to treat certain medical conditions.
This report is about Phototherapy device.
Global key players of Phototherapy Treatment include GE Healthcare, Atom Medical, Draeger, Herbert Waldmann, Natus Medical, Daavlin, Beurer and National Biological, etc. Top three players occupy for a share about 19%. North America is the largest market, with a share about 31%, followed by Europe and Asia-Pacific. In terms of product, LED Phototherapy Treatment is the largest segment, with a share over 59%. In terms of application, Hospital and Clinic is the largest market, with a share over 84%.
Read the full market overview
Report Includes
This report presents an overview of global market for Phototherapy Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Phototherapy Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Phototherapy Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phototherapy Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Phototherapy Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Phototherapy Treatment revenue, projected growth trends, production technology, application and end-user industry.
Phototherapy Treatment Segment by Company
GE Healthcare
Atom Medical
Draeger
Herbert Waldmann
Natus Medical
Daavlin
Beurer
National Biological
DAVID
Solarc Systems Inc.
UVBioTek
MTTS Asia
Nice Neotech
Phototherapy Treatment Segment by Type
Conventional
LED
Fiberoptic
Phototherapy Treatment Segment by Application
Hospital & Clinic
Home
Phototherapy Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phototherapy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phototherapy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phototherapy Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Phototherapy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Phototherapy Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phototherapy Treatment revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional
- LED
- Fiberoptic
Applications
- Hospital & Clinic
- Home
Companies covered
- GE Healthcare
- Atom Medical
- Draeger
- Herbert Waldmann
- Natus Medical
- Daavlin
- Beurer
- National Biological
- DAVID
- Solarc Systems Inc.
- UVBioTek
- MTTS Asia
- Nice Neotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Phototherapy Treatment Market by Type
- 1.2.1 Global Phototherapy Treatment Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Conventional
- 1.2.3 LED
- 1.2.4 Fiberoptic
- 1.3 Phototherapy Treatment Market by Application
- 1.3.1 Global Phototherapy Treatment Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital & Clinic
- 1.3.3 Home
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Phototherapy Treatment Market Dynamics
- 2.1 Phototherapy Treatment Industry Trends
- 2.2 Phototherapy Treatment Industry Drivers
- 2.3 Phototherapy Treatment Industry Opportunities and Challenges
- 2.4 Phototherapy Treatment Industry Restraints
3 Global Growth Perspective
- 3.1 Global Phototherapy Treatment Market Perspective (2021-2032)
- 3.2 Global Phototherapy Treatment Growth Trends by Region
- 3.2.1 Global Phototherapy Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Phototherapy Treatment Market Size by Region (2021-2026)
- 3.2.3 Global Phototherapy Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Phototherapy Treatment Revenue by Players
- 4.1.1 Global Phototherapy Treatment Revenue by Players (2021-2026)
- 4.1.2 Global Phototherapy Treatment Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Phototherapy Treatment Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Phototherapy Treatment Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Phototherapy Treatment Key Players Headquarters & Area Served
- 4.4 Global Phototherapy Treatment Players, Product Type & Application
- 4.5 Global Phototherapy Treatment Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Phototherapy Treatment Market CR5 and HHI
- 4.6.3 2025 Phototherapy Treatment Tier 1, Tier 2, and Tier 3
5 Phototherapy Treatment Market Size by Type
- 5.1 Global Phototherapy Treatment Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Phototherapy Treatment Revenue by Type (2021-2032)
- 5.3 Global Phototherapy Treatment Revenue Market Share by Type (2021-2032)
6 Phototherapy Treatment Market Size by Application
- 6.1 Global Phototherapy Treatment Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Phototherapy Treatment Revenue by Application (2021-2032)
- 6.3 Global Phototherapy Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 GE Healthcare
- 7.1.1 GE Healthcare Company Information
- 7.1.2 GE Healthcare Business Overview
- 7.1.3 GE Healthcare Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.1.4 GE Healthcare Phototherapy Treatment Product Portfolio
- 7.1.5 GE Healthcare Recent Developments
- 7.2 Atom Medical
- 7.2.1 Atom Medical Company Information
- 7.2.2 Atom Medical Business Overview
- 7.2.3 Atom Medical Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.2.4 Atom Medical Phototherapy Treatment Product Portfolio
- 7.2.5 Atom Medical Recent Developments
- 7.3 Draeger
- 7.3.1 Draeger Company Information
- 7.3.2 Draeger Business Overview
- 7.3.3 Draeger Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.3.4 Draeger Phototherapy Treatment Product Portfolio
- 7.3.5 Draeger Recent Developments
- 7.4 Herbert Waldmann
- 7.4.1 Herbert Waldmann Company Information
- 7.4.2 Herbert Waldmann Business Overview
- 7.4.3 Herbert Waldmann Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.4.4 Herbert Waldmann Phototherapy Treatment Product Portfolio
- 7.4.5 Herbert Waldmann Recent Developments
- 7.5 Natus Medical
- 7.5.1 Natus Medical Company Information
- 7.5.2 Natus Medical Business Overview
- 7.5.3 Natus Medical Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.5.4 Natus Medical Phototherapy Treatment Product Portfolio
- 7.5.5 Natus Medical Recent Developments
- 7.6 Daavlin
- 7.6.1 Daavlin Company Information
- 7.6.2 Daavlin Business Overview
- 7.6.3 Daavlin Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.6.4 Daavlin Phototherapy Treatment Product Portfolio
- 7.6.5 Daavlin Recent Developments
- 7.7 Beurer
- 7.7.1 Beurer Company Information
- 7.7.2 Beurer Business Overview
- 7.7.3 Beurer Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.7.4 Beurer Phototherapy Treatment Product Portfolio
- 7.7.5 Beurer Recent Developments
- 7.8 National Biological
- 7.8.1 National Biological Company Information
- 7.8.2 National Biological Business Overview
- 7.8.3 National Biological Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.8.4 National Biological Phototherapy Treatment Product Portfolio
- 7.8.5 National Biological Recent Developments
- 7.9 DAVID
- 7.9.1 DAVID Company Information
- 7.9.2 DAVID Business Overview
- 7.9.3 DAVID Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.9.4 DAVID Phototherapy Treatment Product Portfolio
- 7.9.5 DAVID Recent Developments
- 7.10 Solarc Systems Inc.
- 7.10.1 Solarc Systems Inc. Company Information
- 7.10.2 Solarc Systems Inc. Business Overview
- 7.10.3 Solarc Systems Inc. Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.10.4 Solarc Systems Inc. Phototherapy Treatment Product Portfolio
- 7.10.5 Solarc Systems Inc. Recent Developments
- 7.11 UVBioTek
- 7.11.1 UVBioTek Company Information
- 7.11.2 UVBioTek Business Overview
- 7.11.3 UVBioTek Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.11.4 UVBioTek Phototherapy Treatment Product Portfolio
- 7.11.5 UVBioTek Recent Developments
- 7.12 MTTS Asia
- 7.12.1 MTTS Asia Company Information
- 7.12.2 MTTS Asia Business Overview
- 7.12.3 MTTS Asia Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.12.4 MTTS Asia Phototherapy Treatment Product Portfolio
- 7.12.5 MTTS Asia Recent Developments
- 7.13 Nice Neotech
- 7.13.1 Nice Neotech Company Information
- 7.13.2 Nice Neotech Business Overview
- 7.13.3 Nice Neotech Phototherapy Treatment Revenue and Gross Margin (2021-2026)
- 7.13.4 Nice Neotech Phototherapy Treatment Product Portfolio
- 7.13.5 Nice Neotech Recent Developments
8 North America
- 8.1 North America Phototherapy Treatment Revenue (2021-2032)
- 8.2 North America Phototherapy Treatment Revenue by Type (2021-2032)
- 8.2.1 North America Phototherapy Treatment Revenue by Type (2021-2026)
- 8.2.2 North America Phototherapy Treatment Revenue by Type (2027-2032)
- 8.3 North America Phototherapy Treatment Revenue Share by Type (2021-2032)
- 8.4 North America Phototherapy Treatment Revenue by Application (2021-2032)
- 8.4.1 North America Phototherapy Treatment Revenue by Application (2021-2026)
- 8.4.2 North America Phototherapy Treatment Revenue by Application (2027-2032)
- 8.5 North America Phototherapy Treatment Revenue Share by Application (2021-2032)
- 8.6 North America Phototherapy Treatment Revenue by Country
- 8.6.1 North America Phototherapy Treatment Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Phototherapy Treatment Revenue by Country (2021-2026)
- 8.6.3 North America Phototherapy Treatment Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Phototherapy Treatment Revenue (2021-2032)
- 9.2 Europe Phototherapy Treatment Revenue by Type (2021-2032)
- 9.2.1 Europe Phototherapy Treatment Revenue by Type (2021-2026)
- 9.2.2 Europe Phototherapy Treatment Revenue by Type (2027-2032)
- 9.3 Europe Phototherapy Treatment Revenue Share by Type (2021-2032)
- 9.4 Europe Phototherapy Treatment Revenue by Application (2021-2032)
- 9.4.1 Europe Phototherapy Treatment Revenue by Application (2021-2026)
- 9.4.2 Europe Phototherapy Treatment Revenue by Application (2027-2032)
- 9.5 Europe Phototherapy Treatment Revenue Share by Application (2021-2032)
- 9.6 Europe Phototherapy Treatment Revenue by Country
- 9.6.1 Europe Phototherapy Treatment Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Phototherapy Treatment Revenue by Country (2021-2026)
- 9.6.3 Europe Phototherapy Treatment Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Phototherapy Treatment Revenue (2021-2032)
- 10.2 China Phototherapy Treatment Revenue by Type (2021-2032)
- 10.2.1 China Phototherapy Treatment Revenue by Type (2021-2026)
- 10.2.2 China Phototherapy Treatment Revenue by Type (2027-2032)
- 10.3 China Phototherapy Treatment Revenue Share by Type (2021-2032)
- 10.4 China Phototherapy Treatment Revenue by Application (2021-2032)
- 10.4.1 China Phototherapy Treatment Revenue by Application (2021-2026)
- 10.4.2 China Phototherapy Treatment Revenue by Application (2027-2032)
- 10.5 China Phototherapy Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Phototherapy Treatment Revenue (2021-2032)
- 11.2 Asia Phototherapy Treatment Revenue by Type (2021-2032)
- 11.2.1 Asia Phototherapy Treatment Revenue by Type (2021-2026)
- 11.2.2 Asia Phototherapy Treatment Revenue by Type (2027-2032)
- 11.3 Asia Phototherapy Treatment Revenue Share by Type (2021-2032)
- 11.4 Asia Phototherapy Treatment Revenue by Application (2021-2032)
- 11.4.1 Asia Phototherapy Treatment Revenue by Application (2021-2026)
- 11.4.2 Asia Phototherapy Treatment Revenue by Application (2027-2032)
- 11.5 Asia Phototherapy Treatment Revenue Share by Application (2021-2032)
- 11.6 Asia Phototherapy Treatment Revenue by Country
- 11.6.1 Asia Phototherapy Treatment Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Phototherapy Treatment Revenue by Country (2021-2026)
- 11.6.3 Asia Phototherapy Treatment Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Phototherapy Treatment Revenue (2021-2032)
- 12.2 SAMEA Phototherapy Treatment Revenue by Type (2021-2032)
- 12.2.1 SAMEA Phototherapy Treatment Revenue by Type (2021-2026)
- 12.2.2 SAMEA Phototherapy Treatment Revenue by Type (2027-2032)
- 12.3 SAMEA Phototherapy Treatment Revenue Share by Type (2021-2032)
- 12.4 SAMEA Phototherapy Treatment Revenue by Application (2021-2032)
- 12.4.1 SAMEA Phototherapy Treatment Revenue by Application (2021-2026)
- 12.4.2 SAMEA Phototherapy Treatment Revenue by Application (2027-2032)
- 12.5 SAMEA Phototherapy Treatment Revenue Share by Application (2021-2032)
- 12.6 SAMEA Phototherapy Treatment Revenue by Country
- 12.6.1 SAMEA Phototherapy Treatment Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Phototherapy Treatment Revenue by Country (2021-2026)
- 12.6.3 SAMEA Phototherapy Treatment Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst